Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.23 by 39.13 percent. This is a 54.84 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $620.39 million which missed the analyst consensus estimate of $630.68 million by 1.63 percent. This is a 53.43 percent increase over sales of $404.36 million the same period last year.